[Intermediate-dose cytosine arabinoside in combination with mitoxantrone in the treatment of refractory leukemia]. 1988

H Takeyama, and H Fukutani, and T Takeo, and H Yamada, and E Watanabe

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008942 Mitoxantrone An anthracenedione-derived antineoplastic agent. Mitozantrone,CL-232325,DHAQ,Mitoxantrone Acetate,Mitoxantrone Hydrochloride,Mitroxone,NSC-279836,NSC-287836,NSC-299195,NSC-301739,NSC-301739D,Novantron,Novantrone,Onkotrone,Pralifan,Ralenova,Acetate, Mitoxantrone,CL 232325,CL232325,Hydrochloride, Mitoxantrone,NSC 279836,NSC 287836,NSC 299195,NSC 301739,NSC 301739D,NSC279836,NSC287836,NSC299195,NSC301739,NSC301739D
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H Takeyama, and H Fukutani, and T Takeo, and H Yamada, and E Watanabe
June 1987, Seminars in oncology,
H Takeyama, and H Fukutani, and T Takeo, and H Yamada, and E Watanabe
June 1987, Seminars in oncology,
H Takeyama, and H Fukutani, and T Takeo, and H Yamada, and E Watanabe
January 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
H Takeyama, and H Fukutani, and T Takeo, and H Yamada, and E Watanabe
September 1990, American journal of hematology,
H Takeyama, and H Fukutani, and T Takeo, and H Yamada, and E Watanabe
August 1988, Cancer,
H Takeyama, and H Fukutani, and T Takeo, and H Yamada, and E Watanabe
January 1989, Haematologica,
H Takeyama, and H Fukutani, and T Takeo, and H Yamada, and E Watanabe
January 1990, Cancer,
H Takeyama, and H Fukutani, and T Takeo, and H Yamada, and E Watanabe
January 1985, Neoplasma,
H Takeyama, and H Fukutani, and T Takeo, and H Yamada, and E Watanabe
September 1990, Leukemia,
H Takeyama, and H Fukutani, and T Takeo, and H Yamada, and E Watanabe
February 1987, Onkologie,
Copied contents to your clipboard!